Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Breast 1

Conditions

Neoplasms 1Motor Activity 1Fatigue 1Breast Neoplasms 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × OTHER × Karnofsky Performance Status × Clear all
NCT00735111 2013-01-17

Do Self-Rated Performance Status Scores Correlate With Health-Care-Provider-Scores?

University of Florida

Phase NA Completed
200 enrolled
Tumor-Agnostic

Neoplasms

NCT00421057 2012-07-31

Combined Strength Training and Functional Endurance Exercise Regimen on Cancer -Related Fatigue and Physical Performance

M.D. Anderson Cancer Center

Completed
25 enrolled
Breast

Breast Neoplasms, Fatigue, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡